Works matching IS 20406223 AND DT 2020 AND VI 11


Results: 74
    1
    2
    3
    4
    5

    Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial.

    Published in:
    Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320959248
    By:
    • Breder, Ikaro;
    • Cunha Breder, Jessica;
    • Bonilha, Isabella;
    • Munhoz, Daniel B.;
    • Medorima, Sheila T. Kimura;
    • Oliveira, Daniela C.;
    • Carmo, Helison R. do;
    • Moreira, Camila;
    • Kontush, Anatol;
    • Zimetti, Francesca;
    • Zanotti, Ilaria;
    • Carvalho, Luiz Sergio F.;
    • Nadruz, Wilson;
    • Muscelli, Elza;
    • Quinaglia, Thiago;
    • Sposito, Andrei C.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism.

    Published in:
    Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320944792
    By:
    • Liao, Hung-Wei;
    • Wang, Shuo-Meng;
    • Chan, Chieh-Kai;
    • Lin, Yen-Hung;
    • Lin, Po-Chih;
    • Ho, Chen-Hsun;
    • Liu, Yu-Chun;
    • Chueh, Jeff S;
    • Wu, Vin-Cent;
    • Lai, Tai-Shuan;
    • Yang, Shao-Yu;
    • Liu, Kao-Lang;
    • Chang, Chin-Chen;
    • Lee, Bo-Chiag;
    • Huang, Kuo-How;
    • Lin, Lian-Yu;
    • Liao, Shih-Cheng;
    • Yen, Ruoh-Fang;
    • Lu, Ching-Chu;
    • Er, Leay-Kiaw
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition.

    Published in:
    Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320942042
    By:
    • Bestion, Eloïne;
    • Jilkova, Zuzana Macek;
    • Mège, Jean-Louis;
    • Novello, Marie;
    • Kurma, Keerthi;
    • Pour, Seyedeh Tayebeh Ahmad;
    • Lalmanach, Gilles;
    • Vanderlynden, Lise;
    • Fizanne, Lionel;
    • Bassissi, Firas;
    • Rachid, Madani;
    • Tracz, Jennifer;
    • Boursier, Jérôme;
    • Courcambeck, Jérôme;
    • Serdjebi, Cindy;
    • Ansaldi, Christelle;
    • Decaens, Thomas;
    • Halfon, Philippe;
    • Brun, Sonia
    Publication type:
    Article
    30
    31
    32
    33

    GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition.

    Published in:
    Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320942042
    By:
    • Bestion, Eloïne;
    • Jilkova, Zuzana Macek;
    • Mège, Jean-Louis;
    • Novello, Marie;
    • Kurma, Keerthi;
    • Pour, Seyedeh Tayebeh Ahmad;
    • Lalmanach, Gilles;
    • Vanderlynden, Lise;
    • Fizanne, Lionel;
    • Bassissi, Firas;
    • Rachid, Madani;
    • Tracz, Jennifer;
    • Boursier, Jérôme;
    • Courcambeck, Jérôme;
    • Serdjebi, Cindy;
    • Ansaldi, Christelle;
    • Decaens, Thomas;
    • Halfon, Philippe;
    • Brun, Sonia
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40

    OXY-SCORE: a new perspective for left ventricular hypertrophy diagnosis.

    Published in:
    Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320936417
    By:
    • Quintana-Villamandos, Begoña;
    • Pazó-Sayós, Laia;
    • González del Pozo, Irene;
    • Rodríguez-Rodríguez, Pilar;
    • Bellón, Jose María;
    • Pedraz-Prieto, Álvaro;
    • Pinto, Ángel G;
    • González, Maria Carmen
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50